cephalosporin c has been researched along with Fever of Unknown Origin in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (16.00) | 18.7374 |
1990's | 7 (28.00) | 18.2507 |
2000's | 6 (24.00) | 29.6817 |
2010's | 8 (32.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Walker, MD | 1 |
Barberán, J | 1 |
Doron, SI; Epstein, L; Logvinenko, T; Muldoon, EG; Murray, S; Snydman, DR | 1 |
Brackett, J; Gruner, S; Lindsay, H | 1 |
Berneman, ZN; Goossens, H; Mebis, J | 1 |
Bastús, R; Cirera, L; Estany, C; Estrada, C; Garau, J; Gómez, I; Gómez, L; Márquez, M; Martí, JM; Quintana, S | 1 |
Cooper, C; Kim, PW; Kornegay, C; Nambiar, S; Rochester, G; Valappil, T; Wang, Y; Wu, YT | 1 |
Kalil, AC | 1 |
Beyene, J; Dupuis, LL; Lehrnbecher, T; Manji, A; Sung, L | 1 |
de Ciman, R; Gross, U; Zimmermann, O | 1 |
Bertone, JJ | 1 |
Stiefelhagen, P | 1 |
Commers, J; Cotton, D; Gress, J; Hathorn, J; Hiemenz, J; Longo, D; Marshall, D; Pizzo, PA; Robichaud, KJ | 1 |
Aquino, VM; Buchanan, GR; Mustafa, MM; Pappo, A; Tkaczewski, I | 1 |
Bartolozzi, S; Castello, MA; Clerico, A; Minori, A; Properzi, E | 1 |
Filatov, LB; Iarikova, EN; Isaev, VG; Kaletin, GI; Kaporskaia, TS; Kliasova, GA; Klimko, NN; Lapin, VA; Medvedeva, NV; Parovichnikova, EN; Porokhona, ON; Pristupa, AS; Rekhtman, GB; Rossiev, VA; Savchenko, VG; Sharov, LN; Tolkacheva, TV; Tumakov, VA | 1 |
Castagnola, E; Dini, G; Giacchino, R; Lanino, E; Viscoli, C | 1 |
Baudard, M; Bouvet, A; Chast, F; Delmer, A; Legrand, O; Levy, V; Marie, JP; Marjanovic, Z; Rio, B; Vekhoff, A; Zittoun, R | 1 |
Egerer, G; Ehrhard, I; Goldschmidt, H; Haas, R; Sonntag, HG; Streich, N | 1 |
Antabli, BA; Bross, P; Siegel, RS; Small, CD; Tabbara, IA | 1 |
Chastagner, P; Eyer, D; Lozniewski, A; Plesiat, P; Plouvier, E; Sommelet, D | 1 |
Armada, A; Cáceres, E; Casimir, L; Debbag, R; Fernández, C; Firpo, V; Latella, A; Paganini, H; Rodriguez-Brieshcke, T; Zubizarreta, P | 1 |
Bodey, GP; Ketchel, SJ; Rodriguez, V | 1 |
Moberg, PJ; Schedvins, K | 1 |
Atogami, S; Itoyama, T; Kamihira, S; Kohno, T; Maeda, T; Moriuchi, Y; Sasagawa, I; Tomonaga, M; Tsukasaki, K; Yamaguchi, K | 1 |
4 review(s) available for cephalosporin c and Fever of Unknown Origin
Article | Year |
---|---|
Possible clinical indications of ceftobiprole.
Topics: Anti-Bacterial Agents; Bacterial Infections; Catheter-Related Infections; Cephalosporins; Cross Infection; Diabetic Foot; Fever of Unknown Origin; Humans; Inpatients; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections | 2019 |
Cefepime-Induced Neurotoxicity Despite Dose Adjustment for Renal Disease: A Brief Report and Review of the Literature.
Topics: Adolescent; Anti-Bacterial Agents; Cefepime; Cephalosporins; Fever of Unknown Origin; Humans; Male; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Renal Insufficiency | 2017 |
Meta-analysis of a possible signal of increased mortality associated with cefepime use.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Female; Fever of Unknown Origin; Humans; Infant; Infant, Newborn; Male; Middle Aged; Neutropenia; Pneumonia, Bacterial; Skin Diseases, Bacterial; Survival Analysis; Urinary Tract Infections; Young Adult | 2010 |
A meta-analysis of antipseudomonal penicillins and cephalosporins in pediatric patients with fever and neutropenia.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Therapy, Combination; Fever of Unknown Origin; Hospitals, Pediatric; Humans; Neutropenia; Penicillins; Treatment Outcome | 2012 |
8 trial(s) available for cephalosporin c and Fever of Unknown Origin
Article | Year |
---|---|
Low-dose beta-lactam plus amikacin in febrile neutropenia: cefepime vs. piperacillin/tazobactam, a randomized trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Fever of Unknown Origin; Humans; Incidence; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Poisoning; Prospective Studies; Treatment Outcome; Young Adult | 2010 |
Ceftriaxone as a single agent in empirical therapy of unexplained fever in granulocytopenic children with solid tumors.
Topics: Adolescent; Agranulocytosis; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Female; Fever of Unknown Origin; Humans; Infant; Male; Neoplasms; Prospective Studies; Risk Factors | 1997 |
[The empirical antibiotic therapy of patients with acute leukemias: the results of a multicenter study].
Topics: Acute Disease; Adult; Ampicillin; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Drug Therapy, Combination; Fever of Unknown Origin; Fluconazole; Gentamicins; Humans; Leukemia; Russia; Sulbactam; Time Factors; Ukraine | 1998 |
Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
Topics: Adult; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Bacterial Infections; Case-Control Studies; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Fever of Unknown Origin; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Tazobactam; Tobramycin; Vancomycin | 1999 |
Empiric antimicrobial therapy of febrile neutropenic patients undergoing haematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Bone Marrow Transplantation; Ceftazidime; Cephalosporins; Ciprofloxacin; Female; Fever; Fever of Unknown Origin; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Neoplasms; Neutropenia | 1999 |
Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Cefixime; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Female; Fever; Fever of Unknown Origin; Humans; Infant; Infusions, Intravenous; Male; Neoplasms; Neutropenia; Risk Factors; Treatment Outcome | 2001 |
A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients.
Topics: Bacterial Infections; Carbenicillin; Cefamandole; Cephalosporins; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Male; Middle Aged; Neoplasms; Tobramycin | 1979 |
Prevention of postoperative infection in cesarean section after rupture of the membranes.
Topics: Cefadroxil; Cefuroxime; Cephalosporins; Cesarean Section; Clinical Trials as Topic; Endometritis; Extraembryonic Membranes; Female; Fever of Unknown Origin; Humans; Labor, Obstetric; Postoperative Complications; Pregnancy; Premedication; Random Allocation; Surgical Wound Infection; Time Factors | 1986 |
13 other study(ies) available for cephalosporin c and Fever of Unknown Origin
Article | Year |
---|---|
Leptospirosis: the possible risk to those participating in water-based sports and activities.
Topics: Athletes; Cephalosporins; Community-Acquired Infections; Environmental Exposure; Fever of Unknown Origin; Humans; Leptospirosis; Occupational Exposure; Penicillins; Primary Health Care; Risk Factors; Swimming; Travel; United Kingdom; Watchful Waiting | 2018 |
The impact of cefepime as first line therapy for neutropenic fever on Clostridium difficile rates among hematology and oncology patients.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Clostridioides difficile; Clostridium Infections; Fever of Unknown Origin; Hematologic Neoplasms; Humans; Neutropenia; Retrospective Studies | 2013 |
Cefepime and mortality.
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Fever of Unknown Origin; Humans; Neutropenia | 2009 |
Is cefepime safe for clinical use? A Bayesian viewpoint.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cephalosporins; Fever of Unknown Origin; Humans; Incidence; Neutropenia; Skin Diseases, Bacterial; Statistics as Topic; United States | 2011 |
Bacteremia among Kenyan Children.
Topics: Bacteremia; Cephalosporins; Ciprofloxacin; Fever of Unknown Origin; Ghana; Humans; Microbial Sensitivity Tests; Salmonella typhi | 2005 |
Fever of unknown origin secondary to occult pleuropneumonia.
Topics: Animals; Anti-Bacterial Agents; Biopsy, Needle; Cephalosporins; Female; Fever of Unknown Origin; Horse Diseases; Horses; Pleuropneumonia; Thoracic Cavity; Treatment Outcome; Ultrasonography | 2006 |
[Lung treated instead of buttocks].
Topics: Abscess; Accidental Falls; Aged; Alzheimer Disease; Anti-Bacterial Agents; Bronchopneumonia; Buttocks; Cephalosporins; Drainage; Female; Fever of Unknown Origin; Follow-Up Studies; Hematoma; Humans; Time Factors; Treatment Outcome; Ultrasonography | 2007 |
Approaching the controversies in antibacterial management of cancer patients.
Topics: Agranulocytosis; Antibodies, Bacterial; Antibody Formation; Bacterial Infections; Ceftazidime; Cephalosporins; Cerebrospinal Fluid Shunts; Drug Synergism; Fever of Unknown Origin; Foreign Bodies; Humans; Mycoses; Neoplasms; Penicillins; Respiratory Tract Infections; Risk | 1984 |
A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia.
Topics: Adolescent; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Female; Fever of Unknown Origin; Humans; Infant; Infusions, Intravenous; Leukocyte Count; Male; Neoplasms; Neutropenia; Neutrophils; Platelet Count; Treatment Outcome | 1996 |
Strategies for cost-containment: once-daily ceftriaxone plus amikacin as empiric therapy for febrile granulocytopenic children with cancer.
Topics: Adolescent; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cost Control; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Infant; Male; Neoplasms; Retrospective Studies; Treatment Outcome | 1999 |
Ceftazidime in combination with glycopeptide antibiotic is an effective first-line therapy for patients undergoing high-dose therapy with autologous peripheral blood stem cell support.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Administration Schedule; Drug Eruptions; Drug Therapy, Combination; Female; Fever of Unknown Origin; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Retrospective Studies; Teicoplanin; Treatment Outcome; Vancomycin | 1999 |
Efficacy of cefepime and amikacin in the empiric treatment of febrile neutropenic children with cancer.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Escherichia coli Infections; Female; Fever; Fever of Unknown Origin; Humans; Infant; Male; Neoplasms; Neutropenia; Staphylococcal Infections; Streptococcal Infections; Treatment Outcome | 2000 |
[Combined antibiotic therapy of infections in patients with acute leukemia].
Topics: Acute Disease; Adult; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Therapy, Combination; Fever of Unknown Origin; Humans; Infections; Leukemia; Middle Aged; Piperacillin; Ticarcillin | 1988 |